Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intention-based Therapy for Autism Spectrum Disorder: Promising Results of a Wait-List Control Study in Children

NCT00503191 is registered in ClinicalTrials.gov with NeuroModulation Technique Research Institute as lead sponsor.

NCT NCT00503191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00503191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intention-based Therapy for Autism Spectrum Disorder: Promising Results of a Wait-List Control Study in Children
Lead sponsor
NeuroModulation Technique Research Institute
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2007
Completion date
February 28, 2009
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism, neurodevelopmental disorder